The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
GlobalData on MSN16h
Roche secures CE mark for ovarian cancer detection testRoche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
Executive Vice-President of Diagnostics, Africa, at Roche Diagnostics, Dr. Allan Pamba, has urged action against diabetes. He said November is World Diabetes Awareness month, noting non-communicable ...
Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
Objectives Elevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the ...
Request To Download Free Sample of This Strategic Report @- The Global Theranostics Market is at the forefront of healthcare innovation, poised to reach over USD 20.52 Billion by 2026, according to a ...
DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...
The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...
DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...
The global AI in pathology market is projected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024, at a high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback